RNA-based adjuvant CV8102 enhances the immunogenicity of a licensed rabies vaccine in a ﬁrst-in-human trial. EudraCT No. 2013-004514-18.
Pulmonary deposition of fluticasone propionate/formoterol in healthy volunteers, asthmatics and COPD patients with a novel breath-triggered inhaler. Respir Med. 2018;138:107-114.
Lung Deposition of the Dry Powder Fixed Combination Beclometasone Dipropionate Plus Formoterol Fumarate Using NEXThaler® Device in Healthy Subjects, Asthmatic Patients, and COPD Patients. J Aerosol Med Pulm Drug Deliv. 2018;31(5):269-280.
Specialized Trials in Dry Powder Inhaler Development – the Introduction of “in vivo” into Clinical Research, Pharmazeutische Medizin 2018; 20-2, 114-118
Safety and tolerability of a novel inhaled GATA3 mRNA targeting DNAzyme in patients with TH2-driven asthma. J Allergy Clin Immunol. 2015;136(3):797-800.
Peculiarities of the Development of Inhaled Drug Products Pharmazeutische Medizin 2018; 20(2): 120-125